Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpes Genitalis | 1 | 2022 | 43 | 0.790 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2021 | 4 | 0.750 |
Why?
|
| Receptors, Glucocorticoid | 3 | 2018 | 3 | 0.720 |
Why?
|
| Totiviridae | 1 | 2020 | 1 | 0.720 |
Why?
|
| Parasites | 1 | 2020 | 6 | 0.720 |
Why?
|
| Trichomonas vaginalis | 1 | 2020 | 5 | 0.720 |
Why?
|
| Extracellular Vesicles | 1 | 2020 | 5 | 0.710 |
Why?
|
| Medroxyprogesterone Acetate | 3 | 2018 | 44 | 0.690 |
Why?
|
| HIV Seropositivity | 1 | 2022 | 265 | 0.680 |
Why?
|
| Urinary Incontinence | 1 | 2019 | 1 | 0.650 |
Why?
|
| Urinary Tract | 1 | 2019 | 4 | 0.640 |
Why?
|
| Microbiota | 1 | 2019 | 30 | 0.630 |
Why?
|
| Norethindrone | 3 | 2018 | 26 | 0.600 |
Why?
|
| HIV-1 | 3 | 2021 | 1260 | 0.520 |
Why?
|
| Contraceptive Agents | 2 | 2014 | 27 | 0.480 |
Why?
|
| HIV Infections | 4 | 2022 | 5097 | 0.470 |
Why?
|
| Progesterone | 1 | 2014 | 5 | 0.460 |
Why?
|
| Epithelial Cells | 1 | 2014 | 14 | 0.450 |
Why?
|
| Immunity, Innate | 2 | 2022 | 10 | 0.370 |
Why?
|
| Female | 8 | 2022 | 9103 | 0.370 |
Why?
|
| Humans | 10 | 2022 | 14537 | 0.310 |
Why?
|
| Risk Factors | 2 | 2021 | 1475 | 0.250 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2022 | 14 | 0.250 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2022 | 20 | 0.250 |
Why?
|
| Biomarkers | 2 | 2022 | 327 | 0.220 |
Why?
|
| Seroconversion | 1 | 2022 | 5 | 0.200 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2022 | 10 | 0.200 |
Why?
|
| Herpesvirus 2, Human | 1 | 2022 | 43 | 0.200 |
Why?
|
| Interleukin-6 | 1 | 2022 | 51 | 0.200 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 46 | 0.190 |
Why?
|
| Radiation Oncology | 1 | 2021 | 2 | 0.180 |
Why?
|
| Workflow | 1 | 2021 | 4 | 0.180 |
Why?
|
| Medical Audit | 1 | 2021 | 26 | 0.180 |
Why?
|
| Symbiosis | 1 | 2020 | 2 | 0.180 |
Why?
|
| Quality Improvement | 1 | 2021 | 34 | 0.180 |
Why?
|
| Comorbidity | 1 | 2021 | 188 | 0.180 |
Why?
|
| Dysbiosis | 1 | 2020 | 2 | 0.170 |
Why?
|
| Vaginosis, Bacterial | 1 | 2020 | 19 | 0.170 |
Why?
|
| Case-Control Studies | 1 | 2021 | 480 | 0.170 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2021 | 656 | 0.160 |
Why?
|
| Cervix Uteri | 2 | 2020 | 22 | 0.160 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2020 | 103 | 0.160 |
Why?
|
| Receptors, CCR5 | 1 | 2018 | 54 | 0.150 |
Why?
|
| Virus Replication | 1 | 2018 | 88 | 0.140 |
Why?
|
| Animals | 1 | 2020 | 1081 | 0.140 |
Why?
|
| Viral Load | 1 | 2021 | 819 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1422 | 0.130 |
Why?
|
| Prevalence | 1 | 2019 | 1192 | 0.120 |
Why?
|
| Young Adult | 1 | 2021 | 2498 | 0.120 |
Why?
|
| HeLa Cells | 1 | 2014 | 15 | 0.110 |
Why?
|
| Cells, Cultured | 1 | 2014 | 79 | 0.110 |
Why?
|
| Injections | 1 | 2014 | 31 | 0.110 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 1993 | 1 | 0.110 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 1993 | 2 | 0.110 |
Why?
|
| Peripheral Vascular Diseases | 1 | 1993 | 4 | 0.110 |
Why?
|
| Syphilis | 1 | 1993 | 14 | 0.110 |
Why?
|
| Adult | 2 | 2021 | 5913 | 0.110 |
Why?
|
| Male | 2 | 2021 | 6754 | 0.090 |
Why?
|
| South Africa | 2 | 2021 | 7596 | 0.090 |
Why?
|
| Radiotherapy | 1 | 2021 | 3 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2021 | 10 | 0.050 |
Why?
|
| Checklist | 1 | 2021 | 5 | 0.050 |
Why?
|
| Secretory Leukocyte Peptidase Inhibitor | 1 | 2020 | 1 | 0.040 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 5 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 9 | 0.040 |
Why?
|
| Reproductive Tract Infections | 1 | 2020 | 8 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2020 | 19 | 0.040 |
Why?
|
| Zimbabwe | 1 | 2020 | 120 | 0.040 |
Why?
|
| Uganda | 1 | 2020 | 197 | 0.040 |
Why?
|
| Vagina | 1 | 2020 | 91 | 0.040 |
Why?
|
| Mifepristone | 1 | 2018 | 7 | 0.040 |
Why?
|
| CD4-CD8 Ratio | 1 | 2018 | 4 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2018 | 23 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2018 | 39 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 60 | 0.040 |
Why?
|
| CD4 Antigens | 1 | 2018 | 49 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 65 | 0.040 |
Why?
|
| Cell Line | 1 | 2018 | 93 | 0.040 |
Why?
|
| RNA Interference | 1 | 2018 | 45 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 49 | 0.040 |
Why?
|
| Progesterone Congeners | 1 | 2014 | 1 | 0.030 |
Why?
|
| Contraceptives, Oral, Synthetic | 1 | 2014 | 2 | 0.030 |
Why?
|
| Pregnancy | 1 | 2020 | 1862 | 0.030 |
Why?
|
| Amputation | 1 | 1993 | 4 | 0.030 |
Why?
|
| Gangrene | 1 | 1993 | 4 | 0.030 |
Why?
|
| Contraceptive Agents, Female | 1 | 2014 | 47 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2014 | 353 | 0.030 |
Why?
|
| Adolescent | 1 | 2020 | 2985 | 0.020 |
Why?
|
| Middle Aged | 1 | 1993 | 3601 | 0.020 |
Why?
|